patients with ST-segment-elevation myocardial infarction (STEMI) requiring interhospital transfer for primary percutaneous coronary intervention, direct transfer from the STEMI referral hospital to the catheterization laboratory (cath lab) at the STEMI receiving hospital may expedite reperfusion, but can be logistically challenging. Methods and Results-We studied 33 901 STEMI patients transferred for primary percutaneous coronary intervention in the Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines from July 2008 to December 2012. The majority of patients were transferred directly to the cath lab (26 510 [78.2%]), and 7391 patients (21.8%) were transferred first to the hospital emergency department/ward. We observed significant interhospital variation in transfer patterns; only 21% of STEMI receiving hospitals routinely transferred >90% of STEMI patients to the cath lab directly. Compared with patients transferred first to the emergency department/ward, STEMI patients transferred to the cath lab had significantly lower first door-to-balloon times (median 191 versus 116 minutes, P<0.0001). After multivariable logistic regression, patients transferred directly to the cath lab also had lower adjusted mortality risk (odds ratio 0.58, 95% confidence interval 0.51-0.66, P<0.0001). Cardiogenic shock, heart failure signs/symptoms, and nonsystem reasons for reperfusion delay were present in 11%, 15%, and 28% of patients transferred first to the emergency department/ward, respectively. The association of direct cath lab transfer with lower mortality persisted after excluding patients with these reasons for delay to primary percutaneous coronary intervention (adjusted odds ratio 0.62, 95% confidence interval 0.46-0.84, P=0.002). Conclusions-Direct transfer of STEMI patients to the cath lab for primary percutaneous coronary intervention was associated with significantly faster reperfusion and lower mortality risk compared with transfer first to the emergency department/ward. (Circ Cardiovasc Interv. 2015;8:e002477.
A pproximately 1 in 4 patients with ST-segment-elevation myocardial infarction (STEMI) initially present to a hospital that cannot provide immediate primary percutaneous coronary intervention (PCI); therefore, these patients require interhospital transfer for primary PCI. 1 The American College of Cardiology and American Heart Association guidelines recommend expedited transfer of eligible STEMI patients to a PCI-capable hospital for primary PCI with a first medical contact-to-device time goal of ≤120 minutes. 2 Despite these guidelines and the development of regional STEMI systems of care, reperfusion goals are still not being achieved for most transfer patients. 3 Delays at the STEMI referral hospital and during interhospital transportation have been implicated in earlier studies. [4] [5] [6] [7] [8] [9] To date, little is known about potential delays at the STEMI receiving hospital that may be targeted for performance improvement to reduce time-to-treatment delays.
Direct transfer to the cardiac catheterization laboratory (cath lab) by bypassing the emergency department (ED) has been proposed as a means of decreasing time to treatment for STEMI patients who are transported to the hospital by emergency Direct Referring Hospital to Cath Lab Transfer for Primary PCI medical services and have a qualifying prehospital ECG. 10 For STEMI patients who have already been triaged at another acute care hospital, this strategy should also be feasible. 11 Using a national acute myocardial infarction (MI) registry (the National Cardiovascular Data Registry Acute Coronary Treatment and Intervention Outcomes Network Registry-Get With The Guidelines [ACTION Registry-GWTG]), we sought to (1) evaluate the proportion of transfer STEMI patients transported directly to the cath lab at the STEMI receiving hospital; (2) compare patient and hospital characteristic differences between patients who are transferred directly to the cath lab versus those transferred to another location within the STEMI receiving hospital; and (3) examine the association between direct transfer to the cath lab and risk-adjusted patient outcomes.
Methods

Study Population
The ACTION Registry-GWTG is the largest ongoing quality improvement registry of patients hospitalized with acute MI who are treated at >700 hospitals in the United States. As previously described, the ACTION Registry-GWTG collects detailed clinical information for consecutive MI patients, including patient characteristics, care processes, and in-hospital adverse events, using standardized definitions. 12, 13 Each hospital's institutional review board approved participation in the registry, and the requirement for individual informed consent was waived because data are collected without individual patient identifiers. High data quality is achieved via automated system validation and reporting of data completeness and range checks, random auditing of participating centers, and extensive education for data managers. 14 This study examined 43 784 STEMI patients initially triaged at a STEMI referral hospital, then transferred to a PCI-capable STEMI receiving hospital participating in the ACTION Registry-GWTG between July 2008 and December 2012. STEMI was defined as acute MI with persistent ST-segment-elevation >1 mm in ≥2 contiguous leads, a presumed new left bundle branch block or posterior MI on the ECG. We excluded patients who received fibrinolytic therapy (9848 [23%]), as well as those missing information on the location of first evaluation at the STEMI receiving hospital (n=35). Our final study sample comprised 33 901 STEMI patients transferred for possible primary PCI.
Data Definitions
We stratified transferred patients by the location of their first evaluation at the STEMI receiving hospital, as noted on the ACTION Registry-GWTG data collection form. Patients were transferred either (1) directly to the cath lab or (2) to another hospital location (ED or a hospital room in the intensive care unit, coronary care unit, step down unit, telemetry unit, pre/postoperative unit, or general hospital ward). The primary outcome of interest was in-hospital mortality. Secondary outcomes of interest included new onset or acute recurrence of heart failure (HF) and cardiogenic shock during the MI hospitalization. HF was defined as physician documentation or report of HF symptoms (ie, dyspnea on light exertion, orthopnea, fluid retention, rales, jugular venous distension, pulmonary edema on physical examination, or pulmonary edema on chest x-ray presumed to be cardiac dysfunction). A low ejection fraction without clinical evidence of HF did not qualify as HF. Cardiogenic shock was defined as sustained (>30 minutes) hypotension (systolic blood pressure <90 mm Hg), cardiac index <2.2 L/min per m 2 secondary to cardiac dysfunction, or the requirement for parenteral inotropic or vasopressor agents or mechanical support (eg, intra-aortic balloon pump, extracorporeal circulation, ventricular assist devices) to maintain blood pressure and cardiac index above those specified levels during the index hospitalization. Onset of PCI was defined as time of first balloon inflation, time of first treatment of lesion (eg, thrombus aspiration), or time of guidewire introduction if lesion could not be crossed.
Statistical Analyses
Baseline characteristics for the patients in this study were categorized by location of first evaluation at the STEMI receiving hospital (cath lab versus ED/other location) and summarized as percentages for categorical variables and medians with interquartile ranges for continuous variables. Differences between groups were compared using χ 2 tests for categorical variables and the Wilcoxon rank-sum test for continuous variables. For assessing inhospital procedures and time intervals, these tests were stratified by hospital. We presented the variation in proportion of patients directly transferred to the cath lab among all STEMI receiving hospitals in a histogram.
We used a hierarchical logistic regression with hospital as a random effect to examine factors associated with direct transfer to the cath lab. Hierarchical models account for confounding as a result of sites and produce estimates similar to those from ordinary logistic regression, while adjusting for variance among hospitals. Starting from baseline patient, STEMI referral, and STEMI receiving hospital characteristics, we used backward variable selection, keeping only variables with P<0.05. The list of candidate variables is shown in Table 1 .
We used multivariable logistic regression with generalized estimating equation to assess the association between direct transfer to the cath lab with each outcome of interest. This method accounts for within-hospital clustering because patients treated at the same hospital tend to have more similar responses relative to patients treated at other hospitals. 15 Each outcome was adjusted using variables from the previously validated ACTION Registry-GWTG mortality model. 16 In a sensitivity analyses, we repeated each model after excluding patients who initially presented with HF or cardiogenic shock, as well as those with a nonsystem reason for delay or deferral of PCI.
WHAT IS KNOWN
• Twenty-five percent of patients who present with a STsegment-elevation myocardial infarction (STEMI) require interhospital transfer for primary percutaneous coronary intervention.
• American College of Cardiology/American Heart Association guidelines recommend a first medical contact-to-device time goal of ≤120 minutes; however, reperfusion goals are not being achieved for most STEMI transfer patients.
WHAT THE STUDY ADDS
• Twenty-two percent of STEMI patients transferred for primary percutaneous coronary intervention went directly to the emergency department or hospital ward rather than the cardiac catheterization laboratory.
• STEMI patients transferred to the catheterization laboratory directly compared with patients transferred first to the emergency department/ward had significantly lower first door-to-balloon times (medial 191 versus 116 minutes, P<0.0001).
• Patients transferred directly to the catheterization laboratory had lower adjusted mortality risk (odds ratio 0.58, 95% confidence interval 0.51-0.66, P<0.0001) even after excluding patients with cardiogenic shock, heart failure, and nonsystem reasons for delay. Direct Referring Hospital to Cath Lab Transfer for Primary PCI Nonsystem reasons for delay included cardiac arrest, the need for intubation, delay in obtaining consent for catheterization, difficult vascular access, difficulty crossing the lesion, or other reasons leading to delay or deferral of PCI. Additional secondary analyses compared outcomes between direct transfer to the cath lab versus transfer to the ED or transfer to the ward individually.
Statistical significance was defined as P<0.05, with no correction for multiple comparisons. SAS statistical software (version 9.3, SAS Institute, Cary, NC) was used for all calculations. The Duke University Medical Center Institutional Review Board granted a waiver of informed consent and authorization for this study, and the Duke Clinical Research Institute conducted all analyses.
Results
Among 33 901 patients transferred from 2174 STEMI referral hospitals to 458 STEMI receiving hospitals, 78% (26 510) were transferred directly to the cath lab and 22% (7391) were transferred first to another STEMI receiving hospital location (ED/ward). In the latter group, 47% went through the ED and 53.6% arrived directly to a hospital ward.
Baseline Patient and Hospital Characteristics
Compared with patients transferred to the ED/ward, those transferred directly to the cath lab were younger, more Categorical variables are presented as proportions. Continuous variables are presented as medians (25th, 75th percentiles). CABG indicates coronary artery bypass graft surgery; cath, catheterization; CrCl, creatinine clearance; ECG, electrocardiogram; ED, emergency department; HF, heart failure; LBBB, left bundle branch block; MI, myocardial infarction; PCI, percutaneous coronary intervention; SBP, systolic blood pressure; STEMI, ST-segment-elevation myocardial infarction; and ULN, upper limit of normal. Direct Referring Hospital to Cath Lab Transfer for Primary PCI likely to be male, and of white race with no health insurance (Table 2 ). Furthermore, patients transferred directly to the cath lab were less likely to have prior cardiovascular diseases, such as MI, prior coronary revascularization, stroke, and peripheral arterial disease, and were less likely to have medical comorbidities, such as diabetes mellitus, severe renal dysfunction, and chronic lung disease.
Notably, equivocal ECG findings, such as a new left bundle branch block or posterior MI, were present in a minority of patients, but were less likely among patients transferred directly to the cath lab (2% versus 7%, P<0.0001). Cardiogenic shock, which may also require additional evaluation and treatment before reperfusion, was also uncommon, occurring in 7% of patients transferred directly to the cath lab and 11% of those transferred first to the ED/ward (P<0.0001).
STEMI referral hospitals that transferred patients directly to the cath lab were often larger hospitals and more frequently had cardiac catheterization capability, although this service might not have been available around-the-clock (Table 2 ). STEMI receiving hospitals that admitted transfer patients directly to the cath lab were often larger hospitals; the difference in teaching status, although statistically significant, was small. Patients transferred directly to the cath lab were more likely to arrive during business hours (33% versus 29%, P<0.0001) and traveled shorter distances between hospitals. There was significant variation across STEMI receiving hospitals in the proportion of patients who were transferred directly to the cath lab ( Figure 1) . Overall, 28% of hospitals transferred less than half of all patients directly to the cath lab, and only 21% of hospitals transferred >90% of patients directly to the cath lab. Between 2008 and 2012, we observed an increase in the proportion of patients transferred directly to the cath lab, ranging from 75% in mid-2008 to 80% by the end of 2012 ( Figure 2) . In the multivariable model, the top 5 factors associated with lower likelihood of direct cath lab transfer were equivocal ECG findings (such as presumed new left bundle branch block or isolated posterior MI), longer travel distance between hospitals, cardiogenic shock or HF on presentation, advanced age, and arrival during nonbusiness hours (Table 1 ). Other patient characteristics that were associated with a lower likelihood of direct cath lab transfer included renal dysfunction, prior stroke, diabetes mellitus, peripheral arterial disease, and prior coronary artery bypass graft surgery. Patient race and sex were not significant variables in the model. Notably, patients who were uninsured or self-insured were more likely to be transferred directly to the cath lab.
In-Hospital Procedures and Time Intervals
Primary PCI was performed in 96% of patients transferred directly to the cath lab compared with 83% of those transferred to another hospital location (P<0.0001). Among patients who received primary PCI, time to treatment was substantially shorter among patients who were transferred to the cath lab (median first door-to-balloon time 116 versus 191 minutes, P<0.0001). Nonsystem reasons for delay, such as cardiac arrest or need for intubation before PCI, were infrequent, but more common in those who presented first to a noncath lab location (Table 3 ). Even after excluding these patients in a sensitivity analysis, the door-in-to-door-out time remained significantly shorter for patients transferred directly to the cath lab than those transferred to another hospital location (median 50 versus 70 minutes, P<0.0001). Although almost all patients transferred directly to the cath lab underwent cardiac catheterization, of those transferred to another location, 90% ultimately underwent cardiac catheterization and only 8% had a documented contraindication to catheterization. Among those who did not undergo primary PCI, those who were transferred to a noncath lab location were more likely to undergo nonprimary PCI and less likely to receive coronary artery bypass graft surgery.
In-Hospital Outcomes
In-hospital outcomes varied significantly among those transferred to the cath lab versus those transferred to another hospital location. Patients transferred directly to the cath lab had lower overall rates of death (5% versus 11%), HF (6% versus 10%), and cardiogenic shock (6% versus 9%) compared with those transferred first to another hospital location (Table 4) . After multivariable adjustment, the risks of in-hospital death and HF remained significantly lower for patients transferred to the cath lab (adjusted odds ratio 0.58, 95% confidence interval 0.51-0.66, P<0.0001; adjusted odds ratio 0.84, 95% confidence interval 0.76-0.93, P=0.001). There was no significant difference in development of cardiogenic shock between patients transferred to the cath lab or other hospital location (adjusted odds ratio 0.93, 95% confidence interval 0.83-1.05, P=0.25). Furthermore, the unadjusted and adjusted risks of In a sensitivity analysis, we excluded patients who initially presented with HF or cardiogenic shock or had nonsystem reasons for delay or deferral of primary PCI (eg, requirement for intubation or difficulty obtaining consent). Among these patients, 87.8% was transferred directly to the cath lab; baseline characteristics were better balanced between patients transferred to the cath lab versus patients transferred to the ED/ward ( Table II in the Data Supplement). Multivariable adjustment again revealed significantly lower risk of death in patients transferred directly to the cath lab (adjusted odds ratio 0.62, 95% confidence interval 0.46-0.84, P=0.002). No significant difference in development of HF or cardiogenic shock was noted between the 2 groups (Table 4 ). Additionally, after excluding patients who had HF, cardiogenic shock, or nonsystem reasons for delay of primary PCI, the risk of death remained significantly lower among patients transferred to the cath lab compared with those transferred either to a hospital ward or to the ED when analyzed separately ( Table I in 
Discussion
Several insights emerge from this national survey of contemporary STEMI patients initially triaged at a STEMI referral hospital and then transferred for possible primary PCI. First, >1 in 5 patients were transferred to a hospital location other than the cath lab at the STEMI receiving hospital. Second, there was significant variation in the proportion of patients transferred directly to the cath lab across STEMI receiving hospitals. Third, direct transfer to the cath lab was associated with substantially shorter first door-to-balloon times. Finally, *Among patients who did not undergo primary PCI. Direct Referring Hospital to Cath Lab Transfer for Primary PCI the risk of death was significantly lower in patients who were transferred directly to the cath lab than in those transferred first to the ED/ward of the STEMI receiving hospital, even after excluding those who presented with cardiogenic shock or HF or those who had a nonsystem reason for delay in primary PCI. Immediate transfer to a PCI-capable hospital for primary PCI is the recommended triage strategy for STEMI patients who initially arrive at or are transported to a non-PCI capable hospital if a first medical contact-to-device time goal of ≤120 minutes can be achieved. 2 Direct transfer of the patient to the cath lab has been proposed as a means of expediting reperfusion for patients diagnosed with STEMI by a prehospital ECG. 10, [17] [18] [19] A direct-to-cath-laboratory approach is likely feasible for most STEMI patients who are initially triaged at a non-PCI capable hospital. However, our survey of >2000 STEMI referral hospitals and >450 STEMI receiving hospitals in the United States shows that 22% of patients were transferred first to a hospital location other than the cath lab. Patients who were transferred directly to the cath lab had substantially shorter time to treatment: a median 34-minute faster door-to-balloon time at the STEMI receiving hospital and an overall 75-minute faster first door-to-balloon time. The 116-minute median for patients admitted directly to the cath lab definitely meets the guideline-recommended goal of ≤120 minutes. More importantly, these patients had significantly lower mortality compared with those initially evaluated at another STEMI receiving hospital location.
Occasionally, patient factors may require further evaluation and treatment before primary PCI. Eleven percent of patients transferred to a noncath lab location had signs of cardiogenic shock on arrival. Nonsystem reasons for reperfusion delay, including cardiac arrest, need for intubation, or inability to obtain timely informed consent, existed in 28% of patients transferred to a noncath lab location (versus 14% of patients transferred directly to the cath lab). However, many STEMI patients transferred to a noncath lab location had none of these findings. Even after excluding patients with cardiac arrest, HF, and nonsystem reasons for delay, the door-in-to-door-out time remains shorter for patients transferred directly to the cath lab. In part, this may speak to potential clinical reasons for delay in transfer. Alternatively, STEMI care systems that are not set up to facilitate direct to cath lab transfer may also have similar deficits contributing to longer door-in-to-door-out time. Importantly, the association of direct transfer to the cath lab with lower mortality persisted even after excluding patients who presented with hemodynamic instability (ie, cardiogenic shock or signs of HF on admission) and those with other nonsystem reasons for reperfusion delay.
In addition to patient factors, several system factors associated with a delay in transfer to the cath lab were identified. First, substantial variability exists across STEMI receiving hospital practices; only 21% of hospitals routinely (>90% of the time) transferred patients directly to the cath lab, whereas 28% of hospitals transferred <50% of accepted patients directly to the cath lab. There were also geographic differences across the United States in terms of the likelihood of direct cath lab transfer. In multivariable analyses, long interhospital transfer distances and arrival during nonbusiness hours are strong system factors that were independent of patient characteristics and associated with a lower likelihood of direct-to-cath lab transfer. Although our data set was unable to capture cath lab readiness, it is possible that the observed system-wide variation was in some part related to availability of cath lab staffing. However, a previous study showed STEMI patients traveling a median of 39 minutes (interquartile range 25-57 minutes) between hospitals when transferred for primary PCI, 20 which suggests room for improvement in system readiness to accept transfer patients for primary PCI.
Because direct cath lab arrival was associated with substantially shorter time to treatment and lower mortality, this study supports the wide adoption of direct transfer to the cath lab across United States hospitals, yet several factors require consideration. First, regional STEMI systems of care have been proven to shorten time to treatment and reduce STEMI mortality. 9, 11, 21 The application of STEMI care protocols within these networks is a key factor to reducing interhospital practice variability and corresponding treatment delays. 9, 11, 22 Second, the presence of equivocal ECG findings (such as presumed new left bundle branch block or isolated posterior MI) was the strongest factor limiting direct cath lab transfer in our multivariable model. The United States health system tolerates a certain degree of false activation of the cath lab for suspected STEMI patients 23, 24 ; this threshold may need to Table 1 ).
be higher for transfer patients given the greater reperfusion delays (ie, larger care gap) in these patients compared with direct arrival patients. 25 Better infrastructure to support ECG transmission and expedite decision-making would facilitate quality improvement for transfer patients. Third, patients transferred to a noncath lab location also had longer first doorto-balloon times (median 191 versus 116 minutes). Part of this delay may involve the need to stabilize the patient for safe transfer. Other potential explanations include a delay between STEMI diagnosis and the final decision to transfer, the transfer destination, and ambulance availability to transport the patient. Continued efforts to coordinate care and facilitate real-time decision-making between STEMI referral hospitals, emergency medical services, and STEMI receiving hospitals should help mitigate these logistic barriers. 26 Fortunately, since 2008, the proportion of patients transferred directly to the cath lab has increased significantly ( Figure 2 ). Finally, a previous study found a statewide prehospital STEMI strategy to bypass closer hospitals without PCI capability resulted in substantially shortened reperfusion delays, 25 yet this strategy is not possible for all patients and geographic areas.
Limitations
The results of this study need to be interpreted in light of several limitations. First and foremost, these data are observational and, therefore, susceptible to unmeasured confounding and selection bias. Notably, after excluding patients with cardiogenic shock, cardiac arrest, and nonsystem reasons for delay, covariates were more evenly balanced between the 2 groups ( Table II in the Data Supplement) ; however, we cannot assess additional unmeasured confounders. In the absence of randomization, causality between direct transfer to the cath lab and outcomes cannot be concluded. Second, the ACTION Registry-GWTG does not capture details regarding the decision-making for transfer location, such as initial triage, timing of activation, and readiness of the cath lab; therefore, these factors cannot be analyzed as potential causes for system-wide variation. Third, although our sensitivity analyses excluded patients who commonly require further evaluation or treatment before reperfusion, such as cardiogenic shock, cardiac arrest, or delay in obtaining consent, we cannot examine other clinically appropriate reasons to defer primary PCI. Fourth, participation in the ACTION Registry-GWTG is voluntary and likely reflects an inherent hospital interest in quality improvement, which may impact the generalizability of the results. Finally, because only in-hospital mortality is collected in this database, future studies are needed to examine the association with longitudinal outcomes.
Conclusions
In this national survey of STEMI patients transferred for possible primary PCI, >20% of patients were transferred to a hospital location other than the cath lab at the STEMI receiving hospital. We also observed significant variation in the proportion of patients transferred directly to the cath lab across STEMI receiving hospitals. Importantly, the risk of mortality was significantly lower in patients who were transferred directly to the cath lab compared with those transferred to another hospital location. These results should incentivize further efforts to coordinate interhospital systems of care, including STEMI referral hospitals, emergency medical services, and STEMI receiving hospitals, and so outcomes may be optimized among transfer patients.
